Global Non-Oncology Precision Medicine Key Trends and Opportunities to 2027

In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.

Market Analysis and Insights: Global Non-Oncology Precision Medicine Market

In 2020, the global Non-Oncology Precision Medicine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.

Global Non-Oncology Precision Medicine Scope and Market Size

Non-Oncology Precision Medicine market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Oncology Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.

Segment by Type, the Non-Oncology Precision Medicine market is segmented into Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics, etc.

Segment by Application, the Non-Oncology Precision Medicine market is segmented into Infectious Diseases, Neurology, Cardiovascular, Lifestyle and Endocrinology, Gastroenterology, Others, etc.

Regional and Country-level Analysis

The report offers exhaustive assessment of different region-wise and country-wise Non-Oncology Precision Medicine markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.

The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Competitive Landscape and Non-Oncology Precision Medicine Market Share Analysis

Non-Oncology Precision Medicine market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Non-Oncology Precision Medicine business, the date to enter into the Non-Oncology Precision Medicine market, Non-Oncology Precision Medicine product introduction, recent developments, etc.

The major vendors include Abbott Laboratories, Agilent Technologies, Inc., Asuragen, Inc., Almac Group, AstraZeneca PLC, Bristol Myers Squibb, bioMérieux SA., BGI, Danaher Corp., Illumina, Inc., Invitae Corporation, Opko Health, Inc., Teva Pharmaceutical Industries Ltd., etc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Oncology Precision Medicine Market Size by Type: 2016 VS 2021 VS 2027

1.2.2 Applied Sciences

1.2.3 Precision Diagnostics

1.2.4 Digital Health and Information Technology

1.2.5 Precision Therapeutics

1.3 Market by Application

1.3.1 Global Non-Oncology Precision Medicine Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Infectious Diseases

1.3.3 Neurology

1.3.4 Cardiovascular

1.3.5 Lifestyle and Endocrinology

1.3.6 Gastroenterology

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global Non-Oncology Precision Medicine Market Perspective (2016-2027)

2.2 Global Non-Oncology Precision Medicine Growth Trends by Regions

2.2.1 Non-Oncology Precision Medicine Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Non-Oncology Precision Medicine Historic Market Size by Regions (2016-2021)

2.2.3 Non-Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027)

2.3 Industry Trends and Growth Strategy

2.3.1 Non-Oncology Precision Medicine Industry Trends

2.3.2 Non-Oncology Precision Medicine Market Drivers

2.3.3 Non-Oncology Precision Medicine Market Challenges

2.3.4 Non-Oncology Precision Medicine Market Restraints

3.1 Global Top Non-Oncology Precision Medicine Players by Market Size

3.1.1 Players Covered: Ranking by Non-Oncology Precision Medicine Revenue

3.1.2 Global Top Non-Oncology Precision Medicine Players by Revenue (2016-2021)

3.1.3 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2016-2021)

3.1.4 Global Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global Non-Oncology Precision Medicine Market Concentration Ratio

3.2.1 Global Non-Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 5 and Top 10 Players by Non-Oncology Precision Medicine Revenue in 2020

3.3 Non-Oncology Precision Medicine Key Players Head office and Area Served

3.4 Key Players Non-Oncology Precision Medicine Product Solution and Service

3.5 Date of Enter into Non-Oncology Precision Medicine Market

3.6 Mergers & Acquisitions, Expansion Plans

4.1 Global Non-Oncology Precision Medicine Historic Market Size by Type (2016-2021)

4.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2022-2027)

5.1 Global Non-Oncology Precision Medicine Historic Market Size by Application (2016-2021)

5.2 Non-Oncology Precision Medicine Forecasted Market Size by Application (2022-2027)

6.1 North America Non-Oncology Precision Medicine Market Size (2016-2027)

6.2 Key Non-Oncology Precision Medicine Players Market Share in North America (2020-2021)

6.3 North America Non-Oncology Precision Medicine Market Size by Country

6.3.1 North America Non-Oncology Precision Medicine Market Size by Country (2016-2021)

6.3.2 North America Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)

6.4 United States Market Size Analysis

6.4.1 United States Non-Oncology Precision Medicine Market Size (2016-2027)

6.4.2 United States Non-Oncology Precision Medicine Market Size by Type (2016-2027)

6.4.3 United States Non-Oncology Precision Medicine Market Size by Application (2016-2027)

6.5 Canada Market Size Analysis

6.5.1 Canada Non-Oncology Precision Medicine Market Size (2016-2027)

6.5.2 Canada Non-Oncology Precision Medicine Market Size by Type (2016-2027)

6.5.3 Canada Non-Oncology Precision Medicine Market Size by Application (2016-2027)

7.1 Europe Non-Oncology Precision Medicine Market Size (2016-2027)

7.2 Key Non-Oncology Precision Medicine Players Market Share in Europe (2020-2021)

7.3 Europe Non-Oncology Precision Medicine Market Size by Country

7.3.1 Europe Non-Oncology Precision Medicine Market Size by Country (2016-2021)

7.3.2 Europe Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)

7.4 Germany Market Size Analysis

7.4.1 Germany Non-Oncology Precision Medicine Market Size (2016-2027)

7.4.2 Germany Non-Oncology Precision Medicine Market Size by Type (2016-2027)

7.4.3 Germany Non-Oncology Precision Medicine Market Size by Application (2016-2027)

7.5 France Market Size Analysis

7.5.1 France Non-Oncology Precision Medicine Market Size (2016-2027)

7.5.2 France Non-Oncology Precision Medicine Market Size by Type (2016-2027)

7.5.3 France Non-Oncology Precision Medicine Market Size by Application (2016-2027)

7.6 U.K. Market Size Analysis

7.6.1 U.K. Non-Oncology Precision Medicine Market Size (2016-2027)

7.6.2 U.K. Non-Oncology Precision Medicine Market Size by Type (2016-2027)

7.6.3 U.K. Non-Oncology Precision Medicine Market Size by Application (2016-2027)

7.7 Italy Market Size Analysis

7.7.1 Italy Non-Oncology Precision Medicine Market Size (2016-2027)

7.7.2 Italy Non-Oncology Precision Medicine Market Size by Type (2016-2027)

7.7.3 Italy Non-Oncology Precision Medicine Market Size by Application (2016-2027)

7.8 Russia Market Size Analysis

7.8.1 Russia Non-Oncology Precision Medicine Market Size (2016-2027)

7.8.2 Russia Non-Oncology Precision Medicine Market Size by Type (2016-2027)

7.8.3 Russia Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.1 Asia-Pacific Non-Oncology Precision Medicine Market Size (2016-2027)

8.2 Key Non-Oncology Precision Medicine Players Market Share in Asia-Pacific (2020-2021)

8.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region

8.3.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2016-2021)

8.3.2 Asia-Pacific Non-Oncology Precision Medicine Market Size Forecast by Region (2022-2027)

8.4 China Market Size Analysis

8.4.1 China Non-Oncology Precision Medicine Market Size (2016-2027)

8.4.2 China Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.4.3 China Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.5 Japan Market Size Analysis

8.5.1 Japan Non-Oncology Precision Medicine Market Size (2016-2027)

8.5.2 Japan Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.5.3 Japan Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.6 South Korea Market Size Analysis

8.6.1 South Korea Non-Oncology Precision Medicine Market Size (2016-2027)

8.6.2 South Korea Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.6.3 South Korea Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.7 India Market Size Analysis

8.7.1 India Non-Oncology Precision Medicine Market Size (2016-2027)

8.7.2 India Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.7.3 India Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.8 Australia Market Size Analysis

8.8.1 Australia Non-Oncology Precision Medicine Market Size (2016-2027)

8.8.2 Australia Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.8.3 Australia Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.9 China Taiwan Market Size Analysis

8.9.1 China Taiwan Non-Oncology Precision Medicine Market Size (2016-2027)

8.9.2 China Taiwan Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.9.3 China Taiwan Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.10 Indonesia Market Size Analysis

8.10.1 Indonesia Non-Oncology Precision Medicine Market Size (2016-2027)

8.10.2 Indonesia Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.10.3 Indonesia Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.11 Thailand Market Size Analysis

8.11.1 Thailand Non-Oncology Precision Medicine Market Size (2016-2027)

8.11.2 Thailand Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.11.3 Thailand Non-Oncology Precision Medicine Market Size by Application (2016-2027)

8.12 Malaysia Market Size Analysis

8.12.1 Malaysia Non-Oncology Precision Medicine Market Size (2016-2027)

8.12.2 Malaysia Non-Oncology Precision Medicine Market Size by Type (2016-2027)

8.12.3 Malaysia Non-Oncology Precision Medicine Market Size by Application (2016-2027)

9.1 Latin America Non-Oncology Precision Medicine Market Size (2016-2027)

9.2 Key Non-Oncology Precision Medicine Players Market Share in Latin America (2020-2021)

9.3 Latin America Non-Oncology Precision Medicine Market Size by Country

9.3.1 Latin America Non-Oncology Precision Medicine Market Size by Country (2016-2021)

9.3.2 Latin America Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)

9.4 Mexico Market Size Analysis

9.4.1 Mexico Non-Oncology Precision Medicine Market Size (2016-2027)

9.4.2 Mexico Non-Oncology Precision Medicine Market Size by Type (2016-2027)

9.4.3 Mexico Non-Oncology Precision Medicine Market Size by Application (2016-2027)

9.5 Brazil Market Size Analysis

9.5.1 Brazil Non-Oncology Precision Medicine Market Size (2016-2027)

9.5.2 Brazil Non-Oncology Precision Medicine Market Size by Type (2016-2027)

9.5.3 Brazil Non-Oncology Precision Medicine Market Size by Application (2016-2027)

9.6 Argentina Market Size Analysis

9.6.1 Argentina Non-Oncology Precision Medicine Market Size (2016-2027)

9.6.2 Argentina Non-Oncology Precision Medicine Market Size by Type (2016-2027)

9.6.3 Argentina Non-Oncology Precision Medicine Market Size by Application (2016-2027)

10.1 Middle East & Africa Non-Oncology Precision Medicine Market Size (2016-2027)

10.2 Key Non-Oncology Precision Medicine Players Market Share in Middle East & Africa (2020-2021)

10.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country

10.3.1 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2016-2021)

10.3.2 Middle East & Africa Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)

10.4 Turkey Market Size Analysis

10.4.1 Turkey Non-Oncology Precision Medicine Market Size (2016-2027)

10.4.2 Turkey Non-Oncology Precision Medicine Market Size by Type (2016-2027)

10.4.3 Turkey Non-Oncology Precision Medicine Market Size by Application (2016-2027)

10.5 Saudi Arabia Market Size Analysis

10.5.1 Saudi Arabia Non-Oncology Precision Medicine Market Size (2016-2027)

10.5.2 Saudi Arabia Non-Oncology Precision Medicine Market Size by Type (2016-2027)

10.5.3 Saudi Arabia Non-Oncology Precision Medicine Market Size by Application (2016-2027)

10.6 UAE Market Size Analysis

10.6.1 UAE Non-Oncology Precision Medicine Market Size (2016-2027)

10.6.2 UAE Non-Oncology Precision Medicine Market Size by Type (2016-2027)

10.6.3 UAE Non-Oncology Precision Medicine Market Size by Application (2016-2027)

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview and Its Total Revenue

11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Introduction

11.1.4 Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.1.5 Abbott Laboratories Recent Development

11.2 Agilent Technologies, Inc.

11.2.1 Agilent Technologies, Inc. Company Details

11.2.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue

11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Introduction

11.2.4 Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.2.5 Agilent Technologies, Inc. Recent Development

11.3 Asuragen, Inc.

11.3.1 Asuragen, Inc. Company Details

11.3.2 Asuragen, Inc. Business Overview and Its Total Revenue

11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Introduction

11.3.4 Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.3.5 Asuragen, Inc. Recent Development

11.4 Almac Group

11.4.1 Almac Group Company Details

11.4.2 Almac Group Business Overview and Its Total Revenue

11.4.3 Almac Group Non-Oncology Precision Medicine Introduction

11.4.4 Almac Group Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.4.5 Almac Group Recent Development

11.5 AstraZeneca PLC

11.5.1 AstraZeneca PLC Company Details

11.5.2 AstraZeneca PLC Business Overview and Its Total Revenue

11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Introduction

11.5.4 AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.5.5 AstraZeneca PLC Recent Development

11.6 Bristol Myers Squibb

11.6.1 Bristol Myers Squibb Company Details

11.6.2 Bristol Myers Squibb Business Overview and Its Total Revenue

11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Introduction

11.6.4 Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.6.5 Bristol Myers Squibb Recent Development

11.7 bioMérieux SA.

11.7.1 bioMérieux SA. Company Details

11.7.2 bioMérieux SA. Business Overview and Its Total Revenue

11.7.3 bioMérieux SA. Non-Oncology Precision Medicine Introduction

11.7.4 bioMérieux SA. Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.7.5 bioMérieux SA. Recent Development

11.8 BGI

11.8.1 BGI Company Details

11.8.2 BGI Business Overview and Its Total Revenue

11.8.3 BGI Non-Oncology Precision Medicine Introduction

11.8.4 BGI Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.8.5 BGI Recent Development

11.9 Danaher Corp.

11.9.1 Danaher Corp. Company Details

11.9.2 Danaher Corp. Business Overview and Its Total Revenue

11.9.3 Danaher Corp. Non-Oncology Precision Medicine Introduction

11.9.4 Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.9.5 Danaher Corp. Recent Development

11.10 Illumina, Inc.

11.10.1 Illumina, Inc. Company Details

11.10.2 Illumina, Inc. Business Overview and Its Total Revenue

11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Introduction

11.10.4 Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.10.5 Illumina, Inc. Recent Development

11.11 Invitae Corporation

11.11.1 Invitae Corporation Company Details

11.11.2 Invitae Corporation Business Overview and Its Total Revenue

11.11.3 Invitae Corporation Non-Oncology Precision Medicine Introduction

11.11.4 Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.11.5 Invitae Corporation Recent Development

11.12 Opko Health, Inc.

11.12.1 Opko Health, Inc. Company Details

11.12.2 Opko Health, Inc. Business Overview and Its Total Revenue

11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Introduction

11.12.4 Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.12.5 Opko Health, Inc. Recent Development

11.13 Teva Pharmaceutical Industries Ltd.

11.13.1 Teva Pharmaceutical Industries Ltd. Company Details

11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue

11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Introduction

11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2016-2021)

11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Non-Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027

    Table 2. Key Players of Applied Sciences

    Table 3. Key Players of Precision Diagnostics

    Table 4. Key Players of Digital Health and Information Technology

    Table 5. Key Players of Precision Therapeutics

    Table 6. Global Non-Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 7. Global Non-Oncology Precision Medicine Market Size by Region (US$ Million): 2016 VS 2021 VS 2027

    Table 8. Global Non-Oncology Precision Medicine Market Size by Regions (2016-2021) & (US$ Million)

    Table 9. Global Non-Oncology Precision Medicine Market Share by Regions (2016-2021)

    Table 10. Global Non-Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 11. Global Non-Oncology Precision Medicine Market Share by Regions (2022-2027)

    Table 12. Non-Oncology Precision Medicine Market Trends

    Table 13. Non-Oncology Precision Medicine Market Drivers

    Table 14. Non-Oncology Precision Medicine Market Challenges

    Table 15. Non-Oncology Precision Medicine Market Restraints

    Table 16. Ranking of Global Top Non-Oncology Precision Medicine Manufacturers by Revenue (US$ Million) in 2020

    Table 17. Global Non-Oncology Precision Medicine Revenue by Players (2016-2021) & (US$ Million)

    Table 18. Global Non-Oncology Precision Medicine Market Share by Players (2016-2021)

    Table 19. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Oncology Precision Medicine as of 2020)

    Table 20. Global 5 Largest Players Market Share by Non-Oncology Precision Medicine Revenue (CR5 and HHI) (2016-2021)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Non-Oncology Precision Medicine Product Solution and Service

    Table 23. Date of Enter into Non-Oncology Precision Medicine Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Non-Oncology Precision Medicine Market Size by Type (2016-2021) & (US$ Million)

    Table 26. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2016-2021)

    Table 27. Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2022-2027) & (US$ Million)

    Table 28. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2022-2027)

    Table 29. Global Non-Oncology Precision Medicine Market Size by Application (2016-2021) & (US$ Million)

    Table 30. Global Non-Oncology Precision Medicine Revenue Market Share by Application (2016-2021)

    Table 31. Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2022-2027) & (US$ Million)

    Table 32. Global Non-Oncology Precision Medicine Revenue Market Share by Application (2022-2027)

    Table 33. Key Players Non-Oncology Precision Medicine Revenue in North America (2020-2021) (US$ Million)

    Table 34. North America Non-Oncology Precision Medicine Market Size by Countries (2016-2021) & (US$ Million)

    Table 35. North America Non-Oncology Precision Medicine Market Size Share by Countries (2016-2021)

    Table 36. North America Non-Oncology Precision Medicine Market Size by Countries (2022-2027) & (US$ Million)

    Table 37. North America Non-Oncology Precision Medicine Market Size Share by Countries (2022-2027)

    Table 38. Non-Oncology Precision Medicine Market Size (US$ Million) in United States, Breakdown by Type (2016-2021)

    Table 39. Non-Oncology Precision Medicine Market Size (US$ Million) in United States, Breakdown by Type (2022-2027)

    Table 40. Non-Oncology Precision Medicine Market Size (US$ Million) in United States, Breakdown by Application (2016-2021)

    Table 41. Non-Oncology Precision Medicine Market Size (US$ Million) in United States, Breakdown by Application (2022-2027)

    Table 42. Non-Oncology Precision Medicine Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021)

    Table 43. Non-Oncology Precision Medicine Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027)

    Table 44. Non-Oncology Precision Medicine Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021)

    Table 45. Non-Oncology Precision Medicine Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027)

    Table 46. Key Players Non-Oncology Precision Medicine Revenue in Europe (2020-2021) (US$ Million)

    Table 47. Europe Non-Oncology Precision Medicine Market Size by Countries (2016-2021) & (US$ Million)

    Table 48. Europe Non-Oncology Precision Medicine Market Size Share by Countries (2016-2021)

    Table 49. Europe Non-Oncology Precision Medicine Market Size by Countries (2022-2027) & (US$ Million)

    Table 50. Europe Non-Oncology Precision Medicine Market Size Share by Countries (2022-2027)

    Table 51. Non-Oncology Precision Medicine Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021)

    Table 52. Non-Oncology Precision Medicine Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027)

    Table 53. Non-Oncology Precision Medicine Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021)

    Table 54. Non-Oncology Precision Medicine Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027)

    Table 55. Non-Oncology Precision Medicine Market Size (US$ Million) in France, Breakdown by Type (2016-2021)

    Table 56. Non-Oncology Precision Medicine Market Size (US$ Million) in France, Breakdown by Type (2022-2027)

    Table 57. Non-Oncology Precision Medicine Market Size (US$ Million) in France, Breakdown by Application (2016-2021)

    Table 58. Non-Oncology Precision Medicine Market Size (US$ Million) in France, Breakdown by Application (2022-2027)

    Table 59. Non-Oncology Precision Medicine Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021)

    Table 60. Non-Oncology Precision Medicine Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027)

    Table 61. Non-Oncology Precision Medicine Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021)

    Table 62. Non-Oncology Precision Medicine Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027)

    Table 63. Non-Oncology Precision Medicine Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021)

    Table 64. Non-Oncology Precision Medicine Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027)

    Table 65. Non-Oncology Precision Medicine Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021)

    Table 66. Non-Oncology Precision Medicine Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027)

    Table 67. Non-Oncology Precision Medicine Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021)

    Table 68. Non-Oncology Precision Medicine Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027)

    Table 69. Non-Oncology Precision Medicine Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021)

    Table 70. Non-Oncology Precision Medicine Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027)

    Table 71. Key Players Non-Oncology Precision Medicine Revenue in Asia-Pacific (2020-2021) (US$ Million)

    Table 72. Asia-Pacific Non-Oncology Precision Medicine Market Size by Regions (2016-2021) & (US$ Million)

    Table 73. Asia-Pacific Non-Oncology Precision Medicine Market Size by Regions (2022-2027) & (US$ Million)

    Table 74. Non-Oncology Precision Medicine Market Size (US$ Million) in China, Breakdown by Type (2016-2021)

    Table 75. Non-Oncology Precision Medicine Market Size (US$ Million) in China, Breakdown by Type (2022-2027)

    Table 76. Non-Oncology Precision Medicine Market Size (US$ Million) in China, Breakdown by Application (2016-2021)

    Table 77. Non-Oncology Precision Medicine Market Size (US$ Million) in China, Breakdown by Application (2022-2027)

    Table 78. Non-Oncology Precision Medicine Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021)

    Table 79. Non-Oncology Precision Medicine Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027)

    Table 80. Non-Oncology Precision Medicine Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021)

    Table 81. Non-Oncology Precision Medicine Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027)

    Table 82. Non-Oncology Precision Medicine Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021)

    Table 83. Non-Oncology Precision Medicine Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027)

    Table 84. Non-Oncology Precision Medicine Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021)

    Table 85. Non-Oncology Precision Medicine Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027)

    Table 86. Non-Oncology Precision Medicine Market Size (US$ Million) in India, Breakdown by Type (2016-2021)

    Table 87. Non-Oncology Precision Medicine Market Size (US$ Million) in India, Breakdown by Type (2022-2027)

    Table 88. Non-Oncology Precision Medicine Market Size (US$ Million) in India, Breakdown by Application (2016-2021)

    Table 89. Non-Oncology Precision Medicine Market Size (US$ Million) in India, Breakdown by Application (2022-2027)

    Table 90. Non-Oncology Precision Medicine Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021)

    Table 91. Non-Oncology Precision Medicine Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027)

    Table 92. Non-Oncology Precision Medicine Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021)

    Table 93. Non-Oncology Precision Medicine Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027)

    Table 94. Non-Oncology Precision Medicine Market Size (US$ Million) in China Taiwan, Breakdown by Type (2016-2021)

    Table 95. Non-Oncology Precision Medicine Market Size (US$ Million) in China Taiwan, Breakdown by Type (2022-2027)

    Table 96. Non-Oncology Precision Medicine Market Size (US$ Million) in China Taiwan, Breakdown by Application (2016-2021)

    Table 97. Non-Oncology Precision Medicine Market Size (US$ Million) in China Taiwan, Breakdown by Application (2022-2027)

    Table 98. Non-Oncology Precision Medicine Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021)

    Table 99. Non-Oncology Precision Medicine Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027)

    Table 100. Non-Oncology Precision Medicine Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021)

    Table 101. Non-Oncology Precision Medicine Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027)

    Table 102. Key Players Non-Oncology Precision Medicine Revenue in Latin America (2020-2021) (US$ Million)

    Table 103. Latin America Non-Oncology Precision Medicine Market Size by Countries (2016-2021) & (US$ Million)

    Table 104. Latin America Non-Oncology Precision Medicine Market Size by Countries (2022-2027) & (US$ Million)

    Table 105. Non-Oncology Precision Medicine Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021)

    Table 106. Non-Oncology Precision Medicine Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027)

    Table 107. Non-Oncology Precision Medicine Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021)

    Table 108. Non-Oncology Precision Medicine Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027)

    Table 109. Non-Oncology Precision Medicine Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021)

    Table 110. Non-Oncology Precision Medicine Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027)

    Table 111. Non-Oncology Precision Medicine Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021)

    Table 112. Non-Oncology Precision Medicine Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027)

    Table 113. Non-Oncology Precision Medicine Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021)

    Table 114. Non-Oncology Precision Medicine Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027)

    Table 115. Non-Oncology Precision Medicine Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021)

    Table 116. Non-Oncology Precision Medicine Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027)

    Table 117. Key Players Non-Oncology Precision Medicine Revenue in Middle East & Africa (2020-2021) (US$ Million)

    Table 118. Middle East & Africa Non-Oncology Precision Medicine Market Size by Countries (2016-2021) & (US$ Million)

    Table 119. Middle East & Africa Non-Oncology Precision Medicine Market Size by Countries (2022-2027) & (US$ Million)

    Table 120. Non-Oncology Precision Medicine Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021)

    Table 121. Non-Oncology Precision Medicine Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027)

    Table 122. Non-Oncology Precision Medicine Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021)

    Table 123. Non-Oncology Precision Medicine Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027)

    Table 124. Non-Oncology Precision Medicine Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021)

    Table 125. Non-Oncology Precision Medicine Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027)

    Table 126. Non-Oncology Precision Medicine Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021)

    Table 127. Non-Oncology Precision Medicine Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027)

    Table 128. Non-Oncology Precision Medicine Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021)

    Table 129. Non-Oncology Precision Medicine Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027)

    Table 130. Non-Oncology Precision Medicine Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021)

    Table 131. Non-Oncology Precision Medicine Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027)

    Table 132. Abbott Laboratories Company Details

    Table 133. Abbott Laboratories Business Overview

    Table 134. Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 135. Abbott Laboratories Non-Oncology Precision Medicine Non-Oncology Precision Medicine Product

    Table 136. Abbott Laboratories Recent Development

    Table 137. Agilent Technologies, Inc. Company Details

    Table 138. Agilent Technologies, Inc. Business Overview

    Table 139. Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 140. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product

    Table 141. Agilent Technologies, Inc. Recent Development

    Table 142. Asuragen, Inc. Company Details

    Table 143. Asuragen, Inc. Business Overview

    Table 144. Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 145. Asuragen, Inc. Non-Oncology Precision Medicine Product

    Table 146. Asuragen, Inc. Recent Development

    Table 147. Almac Group Company Details

    Table 148. Almac Group Business Overview

    Table 149. Almac Group Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 150. Almac Group Non-Oncology Precision Medicine Product

    Table 151. Almac Group Recent Development

    Table 152. AstraZeneca PLC Company Details

    Table 153. AstraZeneca PLC Business Overview

    Table 154. AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 155. AstraZeneca PLC Non-Oncology Precision Medicine Product

    Table 156. AstraZeneca PLC Recent Development

    Table 157. Bristol Myers Squibb Company Details

    Table 158. Bristol Myers Squibb Business Overview

    Table 159. Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 160. Bristol Myers Squibb Non-Oncology Precision Medicine Product

    Table 161. Bristol Myers Squibb Recent Development

    Table 162. bioMérieux SA. Company Details

    Table 163. bioMérieux SA. Business Overview

    Table 164. bioMérieux SA. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 165. bioMérieux SA. Non-Oncology Precision Medicine Product

    Table 166. bioMérieux SA. Recent Development

    Table 167. BGI Company Details

    Table 168. BGI Business Overview

    Table 169. BGI Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 170. BGI Non-Oncology Precision Medicine Product

    Table 171. BGI Recent Development

    Table 172. Danaher Corp. Company Details

    Table 173. Danaher Corp. Business Overview

    Table 174. Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 175. Danaher Corp. Non-Oncology Precision Medicine Product

    Table 176. Danaher Corp. Recent Development

    Table 177. Illumina, Inc. Company Details

    Table 178. Illumina, Inc. Business Overview

    Table 179. Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 180. Illumina, Inc. Non-Oncology Precision Medicine Product

    Table 181. Illumina, Inc. Recent Development

    Table 182. Invitae Corporation Company Details

    Table 183. Invitae Corporation Business Overview

    Table 184. Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 185. Invitae Corporation Non-Oncology Precision Medicine Product

    Table 186. Invitae Corporation Recent Development

    Table 187. Opko Health, Inc. Company Details

    Table 188. Opko Health, Inc. Business Overview

    Table 189. Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 190. Opko Health, Inc. Non-Oncology Precision Medicine Product

    Table 191. Opko Health, Inc. Recent Development

    Table 192. Teva Pharmaceutical Industries Ltd. Company Details

    Table 193. Teva Pharmaceutical Industries Ltd. Business Overview

    Table 194. Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)

    Table 195. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product

    Table 196. Teva Pharmaceutical Industries Ltd. Recent Development

    Table 197. Research Programs/Design for This Report

    Table 198. Key Data Information from Secondary Sources

    Table 199. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Non-Oncology Precision Medicine Market Share by Type: 2020 & 2027

    Figure 2. Applied Sciences Features

    Figure 3. Precision Diagnostics Features

    Figure 4. Digital Health and Information Technology Features

    Figure 5. Precision Therapeutics Features

    Figure 6. Global Non-Oncology Precision Medicine Market Share by Application: 2020 & 2027

    Figure 7. Infectious Diseases Case Studies

    Figure 8. Neurology Case Studies

    Figure 9. Cardiovascular Case Studies

    Figure 10. Lifestyle and Endocrinology Case Studies

    Figure 11. Gastroenterology Case Studies

    Figure 12. Others Case Studies

    Figure 13. Non-Oncology Precision Medicine Report Years Considered

    Figure 14. Global Non-Oncology Precision Medicine Market Share by Regions: 2016 VS 2021 VS 2027

    Figure 15. Global Non-Oncology Precision Medicine Market Size YoY Growth 2016-2027 (US$ Million)

    Figure 16. Global Non-Oncology Precision Medicine Market Share by Regions (2022-2027)

    Figure 17. Global Non-Oncology Precision Medicine Market Share by Players in 2020

    Figure 18. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Oncology Precision Medicine as of 2020)

    Figure 19. The Top 10 and 5 Players Market Share by Non-Oncology Precision Medicine Revenue in 2020

    Figure 20. North America Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 21. United States Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 22. Canada Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 23. Europe Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 24. Germany Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 25. France Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 26. U.K. Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 27. Italy Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 28. Russia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 29. Asia-Pacific Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 30. China Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. Japan Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. South Korea Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. India Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 34. Australia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 35. China Taiwan Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 36. Indonesia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 37. Thailand Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 38. Malaysia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 39. Latin America Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. Mexico Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. Brazil Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. Argentina Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. Middle East & Africa Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 44. Turkey Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 45. Saudi Arabia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 46. UAE Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 47. Bottom-up and Top-down Approaches for This Report

    Figure 48. Data Triangulation

    Figure 49. Key Executives Interviewed